Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 212 results found. Search for [ dcgi covid vaccine approval ]

Results 1 to 21 of 212
BusinessToday.In
April 19, 2021
The Pune-headquartered company had received approval in December last year to start phase 1 and 2 trials for its COVID-19 vaccine candidate.


Reuters
April 16, 2021
Facing soaring cases and overflowing hospitals after lockdown restrictions were eased, it also abruptly changed the rules to allow it to fast-track vaccine imports, having earlier rebuffed foreign drugmakers like Pfizer


BusinessToday.In
April 16, 2021
In a letter to Maharashtra Chief Secretary Sitaram Kunte, Renu Swarup, Secretary in Department of Biotechnology, said Haffkine Institute can manufacture the vaccine doses.


BusinessToday.In
April 15, 2021
The development comes after DCGI (Drugs Controller General of India) gave its nod to foreign-made and approved COVID-19 vaccines following a massive spike in coronavirus cases


Joe C Mathew
April 15, 2021
India will provide approvals to COVID-19 vaccines approved by health regulators like US FDA within 3 days; detailled guidelines to come soon


Joe C Mathew
April 14, 2021
Addressing a virtual press briefing on April 13, Dmitriev said its vaccine partnership covers 20 producers in 10 countries including Korea, China and India


BusinessToday.In
April 14, 2021
Rahul Gandhi tweeted, citing Mahatma Gandhi's quote: 'First they ignore you. Then they laugh at you. Then they fight you. Then you win'. He also tagged a media report, saying the Centre has fast-tracked emergency approval for foreign-produced jabs.


BusinessToday.In
April 14, 2021
Drug major Dr Reddy's Laboratories is also going to tap domestically sourced jabs as their production speeds up in India


BusinessToday.In
April 13, 2021
Sensex closed 660 points higher at 48,544 and Nifty ended 194 points higher at 14,504. Top Sensex gainers were M&M, Bajaj twins, Maruti suzuki and IndusInd  Bank rising up to 8.02%


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


BusinessToday.In
April 13, 2021
India is the leading production hub for Sputnik V. RDIF has signed pacts with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech to produce over 850 million doses per year


BusinessToday.In
April 5, 2021
Over 91.15% of patients treated with PegIFN were found to be RT PCR negative by day 7 as compared to 78.90 per cent on the 'standard of care' arm; PegIFN reduced the duration for supplemental oxygen to 56 hours from 84 hours in moderate COVID-19 patients


BusinessToday.In
March 31, 2021
The Drug Controller General of India (DCGI) has allowed the extension of AstraZeneca coronavirus vaccine's expiration time period from the earlier prescribed six months


Rai Vinaykumar & Mudit Kapoor
March 13, 2021
India administered 1,87,55,540 first doses of the vaccine in the first 17 days of March. At this rate, it will take 2.36 years for India to vaccinate 70 per cent of its population with the initial dose of the two-dose regime vaccination programme.


PTI
February 22, 2021
The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support


PB Jayakumar
February 19, 2021
The Government is yet to finalise a strategy for vaccinating 27 crore elderly in India in the next phase. The Government target was to vaccinate over three million people per day


BusinessToday.In
February 12, 2021
Chhattisgarh CM had raised two primary concerns regarding Covaxin -- inhibitions on incomplete trials and absence of \"expiration date\". Dr Vardhan says vaccine approved after due evaluation of pre-clinical and clinical trial data and that expiry date is mentioned on its label


BusinessToday.In
February 5, 2021
Cadila says its business in India, which comprises human health formulations, consumer wellness and animal health, posted strong growth during the quarter as it rose 20 per cent on a y-o-y basis and recorded revenues of Rs 1,643 crore


BusinessToday.In
February 5, 2021
Coronavirus vaccine: Pfizer was the first pharmaceutical company to seek EUA from Drugs Controller General of India (DCGI) after its vaccine was approved in the UK and Bahrain


PAGES 1 OF 11  12345